The Effectiveness, Cost-effectiveness, and Budget Impact of Interventions to Improve the Delivery of Cervical Cancer Screening in Puerto Rico.
Launched by UNIVERSITY OF PUERTO RICO COMPREHENSIVE CANCER CENTER · Apr 16, 2025
Trial Information
Current as of June 27, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Aim 1. Conduct a four-arm multi-site randomized controlled trial to evaluate the effectiveness of three interventions, including patient reminders plus patient navigation and self-collection of HPV test (individually and in combination), compared to patient reminders alone on:
1a. Cervical cancer screening (clinic-based pap test/HPV co-testing) uptake among women and completion of HPV self-collection kit.
1. b. Timely colposcopy and high-grade squamous intraepithelial lesion (HSIL) treatment among women with abnormal screening results. Secondary analyses will examine implementation outcom...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • 25-65 years old
- • No history of cervical cancer or hysterectomy
- • Have not had a Pap test in the past 3 years or more, an HPV test in the past 5 years or more, or a combination of a Pap test and an HPV test in the past 5 or more years (co-testing).
- • Must have a record at the study clinics (at least 2 previous visits).
- Exclusion Criteria:
- • Women with no telephone contact information
- • Being pregnant\*
- • Living with HIV, Lupus, or Crohn's\*
- • Active on immunotherapy treatment\*
- • History of organ transplants\*
- • Will be excluded as cervical cancer screening guidelines differ for them.
About University Of Puerto Rico Comprehensive Cancer Center
The University of Puerto Rico Comprehensive Cancer Center (UPRCCC) is a leading academic institution dedicated to advancing cancer research, prevention, and treatment. As a prominent sponsor of clinical trials, UPRCCC leverages its multidisciplinary approach and cutting-edge facilities to foster innovative research that addresses the unique health challenges faced by diverse populations in Puerto Rico and beyond. By collaborating with a network of healthcare professionals and researchers, UPRCCC aims to enhance patient outcomes through rigorous clinical studies, contributing to the global body of knowledge in oncology and improving cancer care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
San Juan, , Puerto Rico
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported